A history of concussion is linked to a significantly higher risk of long-term disability after an MVA, underscoring the need ...

Patients with early Parkinson disease who received lixisenatide had a decrease in motor disability progression, but they also experienced gastrointestinal side effects. Lixisenatide vs placebo is ...

An older diabetes treatment called lixisenatide resulted in less progression of motor disability after 12 months in patients in an early stage of the disease Erin Clack is a Staff Editor for PEOPLE.

A recent study published in The New England Journal of Medicine has demonstrated that lixisenatide, a glucagon-like peptide-1 (GLP-1) receptor agonist, may slow the progression of motor disability in ...

DUARTE, Calif., Aug. 20, 2025 /PRNewswire/ -- A groundbreaking study has revealed something remarkable about premature babies fed Prolacta Bioscience's Exclusive Human Milk Diet (EHMD): Despite being ...

political force? In Detroit, where more than 30% of residents live with a disability, grassroots organizing has led to a groundbreaking victory: $8.4 million in the city’s 2025 budget is now dedicated ...

Please provide your email address to receive an email when new articles are posted on . Students with a chronic illness, sensory or motor disability or multiple disabilities often experience ...